1. Home
  2. HMC vs ZTS Comparison

HMC vs ZTS Comparison

Compare HMC & ZTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Honda Motor Company Ltd.

HMC

Honda Motor Company Ltd.

HOLD

Current Price

$26.82

Market Cap

34.0B

ML Signal

HOLD

Logo Zoetis Inc.

ZTS

Zoetis Inc.

HOLD

Current Price

$79.25

Market Cap

34.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HMC
ZTS
Founded
1946
1952
Country
Japan
United States
Employees
215320
N/A
Industry
Auto Manufacturing
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
34.0B
34.1B
IPO Year
N/A
2012

Fundamental Metrics

Financial Performance
Metric
HMC
ZTS
Price
$26.82
$79.25
Analyst Decision
Hold
Buy
Analyst Count
1
12
Target Price
N/A
$154.18
AVG Volume (30 Days)
2.0M
6.3M
Earning Date
05-13-2026
05-07-2026
Dividend Yield
4.45%
1.86%
EPS Growth
N/A
10.05
EPS
N/A
1.42
Revenue
N/A
$9,467,000,000.00
Revenue This Year
N/A
$5.63
Revenue Next Year
$4.36
$4.77
P/E Ratio
$40.40
$56.30
Revenue Growth
N/A
2.28
52 Week Low
$23.25
$73.82
52 Week High
$34.89
$161.77

Technical Indicators

Market Signals
Indicator
HMC
ZTS
Relative Strength Index (RSI) 53.98 36.13
Support Level $26.09 $74.35
Resistance Level $28.25 $82.34
Average True Range (ATR) 0.45 2.40
MACD -0.08 1.40
Stochastic Oscillator 33.72 49.83

Price Performance

Historical Comparison
HMC
ZTS

About HMC Honda Motor Company Ltd.

Incorporated in 1948, Honda Motor was originally a motorcycle manufacturer. Today, the firm makes automobiles, motorcycles, and power products such as boat engines, generators, and lawnmowers. Including joint ventures, Honda sold 3.4 million light vehicles and 22.1 million motorcycles in fiscal 2026, and consolidated sales were JPY 21.8 trillion. Automobiles constitute 64% of revenue and motorcycles 18%, with the rest split between power products and financial services. Honda also makes robots and private jets.

About ZTS Zoetis Inc.

Zoetis sells anti-infectives, vaccines, parasiticides, diagnostics, and other health products for animals. The firm earns roughly 35% of total revenue from production animals (cattle, pigs, poultry, and so on) and nearly 65% from companion animal (dogs, horses, cats) products. Its US business is skewed even more heavily toward companion animals, while its international business is slightly skewed toward production animals. The firm has the largest market share in the industry and was previously Pfizer's animal health unit.

Share on Social Networks: